Variant report
Variant | nsv561916 |
---|---|
Chromosome Location | chr13:64217694-64236589 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2590930 | chr13:64217694-64217695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143229173 | chr13:64217701-64217702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9539831 | chr13:64217719-64217720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186542731 | chr13:64217750-64217751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148067546 | chr13:64217798-64217799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559874129 | chr13:64217802-64217803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140867893 | chr13:64217803-64217804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192330076 | chr13:64217826-64217827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564214589 | chr13:64217844-64217845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs17088658 | chr13:64217882-64217883 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs114952190 | chr13:64217920-64217921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563035828 | chr13:64217931-64217932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530442933 | chr13:64217934-64217935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548626842 | chr13:64217978-64217979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544376923 | chr13:64218005-64218006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75246393 | chr13:64218013-64218014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527723780 | chr13:64218098-64218099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552108369 | chr13:64218108-64218109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs578043785 | chr13:64218128-64218129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540691252 | chr13:64218198-64218199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570623381 | chr13:64218199-64218200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560286982 | chr13:64218202-64218203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537917794 | chr13:64218305-64218306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77883922 | chr13:64218310-64218311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529245162 | chr13:64218316-64218317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145988126 | chr13:64218336-64218337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535622580 | chr13:64218363-64218364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2587601 | chr13:64218393-64218394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576679370 | chr13:64223221-64223222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146067680 | chr13:64223226-64223227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367959298 | chr13:64223233-64223234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549381065 | chr13:64223240-64223241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562310284 | chr13:64223264-64223265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185239130 | chr13:64223267-64223268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541595702 | chr13:64223273-64223274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535399108 | chr13:64223284-64223285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189629978 | chr13:64223301-64223302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547169046 | chr13:64223307-64223308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571981822 | chr13:64223327-64223328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371466585 | chr13:64223344-64223345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532823165 | chr13:64223355-64223356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569281287 | chr13:64223360-64223361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147849780 | chr13:64223361-64223362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537502090 | chr13:64223379-64223380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569184735 | chr13:64223390-64223391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536631844 | chr13:64223405-64223406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554804157 | chr13:64223531-64223532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566950710 | chr13:64223564-64223565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533741379 | chr13:64223576-64223577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554525527 | chr13:64223580-64223581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64217400-64218400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr13:64223200-64224400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr13:64223600-64224200 | Enhancers | Brain Substantia Nigra | brain |
4 | chr13:64223800-64224200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr13:64224000-64224400 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr13:64224400-64227200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr13:64227200-64227400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr13:64233000-64233600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr13:64235400-64235600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |